Clearsense Funding, Investors & Competitors

Clearsense has raised $101M across 3 funding rounds, most recently a $50M Series D in January 2023.

Last Clearsense funding round

$50M

Series D · Jan 2023

Cumulative funding Clearsense raised

$101M

across 3 funding rounds

Key investors in Clearsense

  • Health Catalyst Capital
  • HealthQuest Capital
  • UPMC Enterprises

Clearsense Overview

About Clearsense

Clearsense is a Jacksonville, Florida-based healthcare data platform that helps hospitals, providers, and payers manage, govern, and analyze clinical, operational, and financial data. Its Clearsense Data Management Platform and DataHub automate data curation, preparation, normalization, and governance, giving healthcare organizations real-time insight into their operations and breaking down silos between systems. The company has also added predictive modeling capabilities to help clinicians and analysts test hypotheses and act on data more quickly.


Founded

2013

HQ

United StatesJacksonville, FL

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

Clearsense Funding History

Clearsense has raised a total of $101M across 3 funding rounds.

Clearsense's first fundraising round was a $21M undisclosed-stage round in November 2018. The most recent completed round was a $50M Series D in January 2023.

Clearsense funding rounds

Clearsense funding rounds
DateStageInvestorsRaisedDeal Summary
Jan 2023Series DHealthQuest Capital (lead); UPMC Enterprises; Health Catalyst Capital$50MClearsense, a Jacksonville, Florida-based PaaS company, partners with healthcare organizations to increase data value, governance, and transparency through its 1Clearsense Data Management Platform. The platform aims to unlock the full potential of healthcare data by delivering solutions that empower data confidence and enable data-driven decision-making for better outcomes. On January 31, 2023, Clearsense announced the successful close of a $50 million Series D funding round led by HealthQuest Capital, with participation from existing investors Health Catalyst Capital and UPMC Enterprises. Piper Sandler served as the sole placement agent and financial advisor. The funding is intended to support Clearsense's growth in 2023 by investing in infrastructure, technology, and personnel to expand the platform and promote data literacy in healthcare. CEO Gene Scheurer highlighted the investment's role in strengthening the company's mission to transform healthcare through improved trust in enterprise data and expanded data-driven operations. HealthQuest Capital, a San Francisco Bay Area-based growth capital firm managing over $1.6 billion, focuses on commercial-stage healthcare companies optimizing outcomes and reducing costs across medical technologies, diagnostics, digital health, and services. Clearsense had previously raised $30 million in 2021, bringing total funding to approximately $127.88 million across 11 rounds as of 2024.
Mar 2021Undisclosed stageHealth Catalyst Capital (lead)$30MClearsense is an advanced data management and analytics technology platform serving the healthcare industry, providing a scalable data platform that enables real-time insights into clinical, operational, and financial metrics. On March 25, 2021, the company closed $30 million in financing led by Health Catalyst Capital, with funds allocated to build out its technology and advisory services to lead enterprise data strategies, including development of the Clearsense DataHub for automating data curation, preparation, normalization, and governance. The investment was highlighted as timely amid healthcare's need to streamline data access and usage, accelerated by COVID-19, where Clearsense's adaptable platform supports providers and payers by breaking industry silos and enabling efficiencies, insights, cost-savings, transparency, and value-based analytics. It operates as an adjunctive solution within any technology landscape, enhancing existing investments. Health Catalyst Capital praised Clearsense's 2020 innovations and resilience, expressing excitement for its advancements in healthcare data maturity. Subsequent rounds include a $50 million Series D in 2023 led by HealthQuest Capital with participation from Health Catalyst Capital and UPMC Enterprises, and further Series D extensions totaling over $127 million raised across 11 rounds as of 2024.
Nov 2018Undisclosed stage-$21M-

Who has invested in Clearsense?

3 investors have backed Clearsense across its funding rounds, including Health Catalyst Capital, HealthQuest Capital and UPMC Enterprises.

Lead investors include HealthQuest Capital and Health Catalyst Capital.


Clearsense Investors

Investors in Clearsense by funding rounds participated
InvestorHQRoundsRoleFirst check
Health Catalyst CapitalUnited StatesNew York City, NY2LeadMar 2021

This data is available for Pro users. Sign up to see all 3 Clearsense investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Clearsense

Clearsense has acquired 1 company to date.

Last acquisition by Clearsense was on September 22nd 2021. Clearsense acquired Compellon for undisclosed valuation.


Latest Acquisitions by Clearsense

Compellon
Description
Compellon is a Boston-based prescriptive analytics platform leveraging AI to deliver optimization recommendations in real-time. The software analyzes complex datasets for retail, manufacturing, and logistics, identifying actions that boost revenue by up to 15 percent. Compellon deploys on-premises or cloud, serving Fortune 500 firms with no-code interfaces for business users, focusing on supply chain and pricing decisions.
HQ CountryUnited States
HQ City
Los Angeles, CA
Deal Date22 Sep 2021
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Clearsense acquisitions and their M&A valuation multiples.

Start Free Trial

Clearsense Competitors

Clearsense competitors include listed companies like Claritev, GE HealthCare, United Imaging and Glaukos, and private ones like Uptake Technologies and Commure.

Public and private companies comparable to Clearsense
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
ClaritevUnited StatesUnited StatesPublicly listed$965M$466M$538M5.2x
Uptake TechnologiesUnited StatesUnited StatesPrivate$100M-$2.3B23.0x
GE HealthCareUnited StatesUnited StatesPublicly listed$21B$3.7B$29B1.8x
United ImagingChinaChinaPublicly listed$2.1B$367M$12B4.8x
GlaukosUnited StatesUnited StatesPublicly listed$507M($157M)$9.5B14.6x
CommureUnited StatesSan Francisco, CAPrivate$200M-$7B35.0x

Clearsense Public Comps

Clearsense is still privately-owned, but its public comps include Palantir, ServiceNow, Datadog, RELX, Strategy, IQVIA, Veeva, IDEXX Laboratories, Roper Technologies and GE HealthCare.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Palantir$4.5B$1.5B92.6x58.1x285.0x97.4x
ServiceNow$13B$2.6B11.1x9.6x57.2x25.0x
Datadog$3.4B($588K)23.6x19.4x(137813.0x)77.6x
RELX$13B$4.9B5.5x5.3x14.4x13.2x
Strategy$477M($5.4B)149.4x144.4x(13.1x)(12.3x)
IQVIA$16B$3.4B3.6x3.4x17.2x14.8x
Veeva$3.2B$965M11.1x10.2x36.9x22.4x
IDEXX Laboratories$4.3B$1.5B9.5x8.9x27.1x24.9x

This data is available for Pro users. Sign up to see all Clearsense competitors and their valuation data.

Start Free Trial

Common questions about Clearsense

When was Clearsense founded?Clearsense was founded in 2013.
Where is Clearsense headquartered?Clearsense is headquartered in Jacksonville, FL, United States.
Is Clearsense publicly listed?No, Clearsense is a private, VC-backed company.
How much funding has Clearsense raised?Clearsense has raised $101M across 3 funding rounds.
What was Clearsense's last funding round?Clearsense's last funding round was a $50M Series D in January 2023, led by HealthQuest Capital.
Who are Clearsense's investors?Clearsense's investors include Health Catalyst Capital, HealthQuest Capital and UPMC Enterprises.
Which companies are comparable to Clearsense?Companies comparable to Clearsense include Claritev, Uptake Technologies, GE HealthCare, United Imaging, Glaukos and Commure.
How many companies has Clearsense acquired?Clearsense has acquired 1 company, including Compellon.

See companies similar to Clearsense

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial